{"id":"https://openalex.org/W2124925985","doi":"https://doi.org/10.1097/00003246-200104000-00015","title":"Randomized, placebo-controlled trial of the anti-tumor necrosis factor antibody fragment afelimomab in hyperinflammatory response during severe sepsis: The RAMSES Study","display_name":"Randomized, placebo-controlled trial of the anti-tumor necrosis factor antibody fragment afelimomab in hyperinflammatory response during severe sepsis: The RAMSES Study","publication_year":2001,"publication_date":"2001-04-01","ids":{"openalex":"https://openalex.org/W2124925985","doi":"https://doi.org/10.1097/00003246-200104000-00015","mag":"2124925985","pmid":"https://pubmed.ncbi.nlm.nih.gov/11373466"},"language":"en","primary_location":{"id":"doi:10.1097/00003246-200104000-00015","doi":"https://doi.org/10.1097/00003246-200104000-00015","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00003246-200104000-00015","pdf_url":null,"source":{"id":"https://openalex.org/S108732581","display_name":"Critical Care Medicine","issn_l":"0090-3493","issn":["0090-3493","1530-0293"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Critical Care Medicine","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103165233","display_name":"Konrad Reinhart","orcid":"https://orcid.org/0000-0002-2324-5444","observed_orcids":["https://orcid.org/0000-0002-2324-5444"]},"institutions":[{"id":"https://openalex.org/I76198965","display_name":"Friedrich Schiller University Jena","ror":"https://ror.org/05qpz1x62","country_code":"DE","type":"education","lineage":["https://openalex.org/I76198965"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Konrad Reinhart","raw_affiliation_strings":["Department of Anesthesia and Operative Intensive Care, Friedrich-Schiller University, Jena, Germany","Belgium","Britain","Germany","Israel","Netherlands","Spain","Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Anesthesia and Operative Intensive Care, Friedrich-Schiller University, Jena, Germany","institution_ids":["https://openalex.org/I76198965"]},{"raw_affiliation_string":"Belgium","institution_ids":[]},{"raw_affiliation_string":"Britain","institution_ids":[]},{"raw_affiliation_string":"Germany","institution_ids":[]},{"raw_affiliation_string":"Israel","institution_ids":[]},{"raw_affiliation_string":"Netherlands","institution_ids":[]},{"raw_affiliation_string":"Spain","institution_ids":[]},{"raw_affiliation_string":"Sweden","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110909538","display_name":"Thilo Menges","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thilo Menges","raw_affiliation_strings":["Belgium","Britain","Germany","Israel","Netherlands","Spain","Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Belgium","institution_ids":[]},{"raw_affiliation_string":"Britain","institution_ids":[]},{"raw_affiliation_string":"Germany","institution_ids":[]},{"raw_affiliation_string":"Israel","institution_ids":[]},{"raw_affiliation_string":"Netherlands","institution_ids":[]},{"raw_affiliation_string":"Spain","institution_ids":[]},{"raw_affiliation_string":"Sweden","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046785338","display_name":"Bengt G\u00e5rdlund","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bengt Gardlund","raw_affiliation_strings":["Belgium","Britain","Germany","Israel","Netherlands","Spain","Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Belgium","institution_ids":[]},{"raw_affiliation_string":"Britain","institution_ids":[]},{"raw_affiliation_string":"Germany","institution_ids":[]},{"raw_affiliation_string":"Israel","institution_ids":[]},{"raw_affiliation_string":"Netherlands","institution_ids":[]},{"raw_affiliation_string":"Spain","institution_ids":[]},{"raw_affiliation_string":"Sweden","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111881359","display_name":"Jan Harm Zwaveling","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jan Harm Zwaveling","raw_affiliation_strings":["Belgium","Britain","Germany","Israel","Netherlands","Spain","Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Belgium","institution_ids":[]},{"raw_affiliation_string":"Britain","institution_ids":[]},{"raw_affiliation_string":"Germany","institution_ids":[]},{"raw_affiliation_string":"Israel","institution_ids":[]},{"raw_affiliation_string":"Netherlands","institution_ids":[]},{"raw_affiliation_string":"Spain","institution_ids":[]},{"raw_affiliation_string":"Sweden","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054320068","display_name":"Mark Smithes","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mark Smithes","raw_affiliation_strings":["Belgium","Britain","Germany","Israel","Netherlands","Spain","Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Belgium","institution_ids":[]},{"raw_affiliation_string":"Britain","institution_ids":[]},{"raw_affiliation_string":"Germany","institution_ids":[]},{"raw_affiliation_string":"Israel","institution_ids":[]},{"raw_affiliation_string":"Netherlands","institution_ids":[]},{"raw_affiliation_string":"Spain","institution_ids":[]},{"raw_affiliation_string":"Sweden","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003379719","display_name":"Jean\u2010Louis Vincent","orcid":"https://orcid.org/0000-0001-6011-6951","observed_orcids":["https://orcid.org/0000-0001-6011-6951"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jean-Louis Vincent","raw_affiliation_strings":["Belgium","Britain","Germany","Israel","Netherlands","Spain","Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Belgium","institution_ids":[]},{"raw_affiliation_string":"Britain","institution_ids":[]},{"raw_affiliation_string":"Germany","institution_ids":[]},{"raw_affiliation_string":"Israel","institution_ids":[]},{"raw_affiliation_string":"Netherlands","institution_ids":[]},{"raw_affiliation_string":"Spain","institution_ids":[]},{"raw_affiliation_string":"Sweden","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084731159","display_name":"Jos\u00e9 M. Tellado","orcid":"https://orcid.org/0000-0002-0384-6517","observed_orcids":["https://orcid.org/0000-0002-0384-6517"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jose Maria Tellado","raw_affiliation_strings":["Belgium","Britain","Germany","Israel","Netherlands","Spain","Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Belgium","institution_ids":[]},{"raw_affiliation_string":"Britain","institution_ids":[]},{"raw_affiliation_string":"Germany","institution_ids":[]},{"raw_affiliation_string":"Israel","institution_ids":[]},{"raw_affiliation_string":"Netherlands","institution_ids":[]},{"raw_affiliation_string":"Spain","institution_ids":[]},{"raw_affiliation_string":"Sweden","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017628737","display_name":"Antonio Salgado-Remigio","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Antonio Salgado-Remigio","raw_affiliation_strings":["Belgium","Britain","Germany","Israel","Netherlands","Spain","Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Belgium","institution_ids":[]},{"raw_affiliation_string":"Britain","institution_ids":[]},{"raw_affiliation_string":"Germany","institution_ids":[]},{"raw_affiliation_string":"Israel","institution_ids":[]},{"raw_affiliation_string":"Netherlands","institution_ids":[]},{"raw_affiliation_string":"Spain","institution_ids":[]},{"raw_affiliation_string":"Sweden","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110404044","display_name":"Reuven Zimlichman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Reuven Zimlichman","raw_affiliation_strings":["Belgium","Britain","Germany","Israel","Netherlands","Spain","Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Belgium","institution_ids":[]},{"raw_affiliation_string":"Britain","institution_ids":[]},{"raw_affiliation_string":"Germany","institution_ids":[]},{"raw_affiliation_string":"Israel","institution_ids":[]},{"raw_affiliation_string":"Netherlands","institution_ids":[]},{"raw_affiliation_string":"Spain","institution_ids":[]},{"raw_affiliation_string":"Sweden","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034495370","display_name":"Stuart Withington","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stuart Withington","raw_affiliation_strings":["Belgium","Britain","Germany","Israel","Netherlands","Spain","Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Belgium","institution_ids":[]},{"raw_affiliation_string":"Britain","institution_ids":[]},{"raw_affiliation_string":"Germany","institution_ids":[]},{"raw_affiliation_string":"Israel","institution_ids":[]},{"raw_affiliation_string":"Netherlands","institution_ids":[]},{"raw_affiliation_string":"Spain","institution_ids":[]},{"raw_affiliation_string":"Sweden","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023876294","display_name":"Klaus Tschaikowsky","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Klaus Tschaikowsky","raw_affiliation_strings":["Belgium","Britain","Germany","Israel","Netherlands","Spain","Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Belgium","institution_ids":[]},{"raw_affiliation_string":"Britain","institution_ids":[]},{"raw_affiliation_string":"Germany","institution_ids":[]},{"raw_affiliation_string":"Israel","institution_ids":[]},{"raw_affiliation_string":"Netherlands","institution_ids":[]},{"raw_affiliation_string":"Spain","institution_ids":[]},{"raw_affiliation_string":"Sweden","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051222987","display_name":"Rainer Brase","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rainer Brase","raw_affiliation_strings":["Belgium","Britain","Germany","Israel","Netherlands","Spain","Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Belgium","institution_ids":[]},{"raw_affiliation_string":"Britain","institution_ids":[]},{"raw_affiliation_string":"Germany","institution_ids":[]},{"raw_affiliation_string":"Israel","institution_ids":[]},{"raw_affiliation_string":"Netherlands","institution_ids":[]},{"raw_affiliation_string":"Spain","institution_ids":[]},{"raw_affiliation_string":"Sweden","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057237977","display_name":"Pierre Damas","orcid":"https://orcid.org/0000-0001-9598-867X","observed_orcids":["https://orcid.org/0000-0001-9598-867X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pierre Damas","raw_affiliation_strings":["Belgium","Britain","Germany","Israel","Netherlands","Spain","Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Belgium","institution_ids":[]},{"raw_affiliation_string":"Britain","institution_ids":[]},{"raw_affiliation_string":"Germany","institution_ids":[]},{"raw_affiliation_string":"Israel","institution_ids":[]},{"raw_affiliation_string":"Netherlands","institution_ids":[]},{"raw_affiliation_string":"Spain","institution_ids":[]},{"raw_affiliation_string":"Sweden","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111703699","display_name":"H. K\u00fcpper","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hartmut Kupper","raw_affiliation_strings":["Belgium","Britain","Germany","Israel","Netherlands","Spain","Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Belgium","institution_ids":[]},{"raw_affiliation_string":"Britain","institution_ids":[]},{"raw_affiliation_string":"Germany","institution_ids":[]},{"raw_affiliation_string":"Israel","institution_ids":[]},{"raw_affiliation_string":"Netherlands","institution_ids":[]},{"raw_affiliation_string":"Spain","institution_ids":[]},{"raw_affiliation_string":"Sweden","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028106526","display_name":"Joachim Kempeni","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joachim Kempeni","raw_affiliation_strings":["Belgium","Britain","Germany","Israel","Netherlands","Spain","Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Belgium","institution_ids":[]},{"raw_affiliation_string":"Britain","institution_ids":[]},{"raw_affiliation_string":"Germany","institution_ids":[]},{"raw_affiliation_string":"Israel","institution_ids":[]},{"raw_affiliation_string":"Netherlands","institution_ids":[]},{"raw_affiliation_string":"Spain","institution_ids":[]},{"raw_affiliation_string":"Sweden","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086048623","display_name":"Juergen Eiselstein","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Juergen Eiselstein","raw_affiliation_strings":["Belgium","Britain","Germany","Israel","Netherlands","Spain","Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Belgium","institution_ids":[]},{"raw_affiliation_string":"Britain","institution_ids":[]},{"raw_affiliation_string":"Germany","institution_ids":[]},{"raw_affiliation_string":"Israel","institution_ids":[]},{"raw_affiliation_string":"Netherlands","institution_ids":[]},{"raw_affiliation_string":"Spain","institution_ids":[]},{"raw_affiliation_string":"Sweden","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5066025130","display_name":"Martin Kaul","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Martin Kaul","raw_affiliation_strings":["Belgium","Britain","Germany","Israel","Netherlands","Spain","Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Belgium","institution_ids":[]},{"raw_affiliation_string":"Britain","institution_ids":[]},{"raw_affiliation_string":"Germany","institution_ids":[]},{"raw_affiliation_string":"Israel","institution_ids":[]},{"raw_affiliation_string":"Netherlands","institution_ids":[]},{"raw_affiliation_string":"Spain","institution_ids":[]},{"raw_affiliation_string":"Sweden","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":17.208,"has_fulltext":false,"cited_by_count":256,"citation_normalized_percentile":{"value":0.99497258,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"29","issue":"4","first_page":"765","last_page":"769"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10218","display_name":"Sepsis Diagnosis and Treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2706","display_name":"Critical Care and Intensive Care Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10218","display_name":"Sepsis Diagnosis and Treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2706","display_name":"Critical Care and Intensive Care Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T14165","display_name":"Inflammation biomarkers and pathways","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11623","display_name":"Hyperglycemia and glycemic control in critically ill and hospitalized patients","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/anti-tnf-monoclonal-antibody","display_name":"anti-TNF monoclonal antibody","score":0.9010000228881836},{"id":"https://openalex.org/keywords/sepsis","display_name":"sepsis","score":0.7979999780654907},{"id":"https://openalex.org/keywords/hyperinflammation","display_name":"hyperinflammation","score":0.8450000286102295},{"id":"https://openalex.org/keywords/interleukin-6","display_name":"interleukin-6","score":0.9800000190734863},{"id":"https://openalex.org/keywords/28-day-mortality","display_name":"28-day mortality","score":0.9160000085830688},{"id":"https://openalex.org/keywords/septic-shock","display_name":"septic shock","score":0.5699999928474426},{"id":"https://openalex.org/keywords/intensive-care-unit-patients","display_name":"intensive care unit patients","score":0.453000009059906}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9408039450645447},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.7511539459228516},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.6628060340881348},{"id":"https://openalex.org/C61943457","wikidata":"https://www.wikidata.org/wiki/Q6046661","display_name":"Interim analysis","level":3,"score":0.6561956405639648},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6543039083480835},{"id":"https://openalex.org/C2778384902","wikidata":"https://www.wikidata.org/wiki/Q183134","display_name":"Sepsis","level":2,"score":0.6012524366378784},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.581295907497406},{"id":"https://openalex.org/C2777628635","wikidata":"https://www.wikidata.org/wiki/Q1765564","display_name":"Septic shock","level":3,"score":0.46396955847740173},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4368338882923126},{"id":"https://openalex.org/C2987404301","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care","level":2,"score":0.42861196398735046},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.35378503799438477},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.10163801908493042},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004797","descriptor_name":"Enzyme-Linked Immunosorbent Assay","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007262","descriptor_name":"Infusions, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012044","descriptor_name":"Regression Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015850","descriptor_name":"Interleukin-6","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D018805","descriptor_name":"Sepsis","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D018805","descriptor_name":"Sepsis","qualifier_ui":"Q000145","qualifier_name":"classification","is_major_topic":false},{"descriptor_ui":"D018805","descriptor_name":"Sepsis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D018805","descriptor_name":"Sepsis","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D018806","descriptor_name":"APACHE","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":6,"locations":[{"id":"doi:10.1097/00003246-200104000-00015","doi":"https://doi.org/10.1097/00003246-200104000-00015","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00003246-200104000-00015","pdf_url":null,"source":{"id":"https://openalex.org/S108732581","display_name":"Critical Care Medicine","issn_l":"0090-3493","issn":["0090-3493","1530-0293"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Critical Care Medicine","raw_type":"journal-article"},{"id":"pmid:11373466","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11373466","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Critical care medicine","raw_type":"Clinical Trial"},{"id":"pmh:oai:dipot.ulb.ac.be:2013/80622","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/80622","pdf_url":null,"source":{"id":"https://openalex.org/S4306401063","display_name":"D\u00e9p\u00f4t institutionnel de l'Universit\u00e9 libre de Bruxelles (Universit\u00e9 Libre de Bruxelles)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I132053463","host_organization_name":"Universit\u00e9 Libre de Bruxelles","host_organization_lineage":["https://openalex.org/I132053463"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Critical care medicine, 29 (4","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:orbi.ulg.ac.be:2268/30945","doi":null,"is_oa":false,"landing_page_url":"https://orbi.uliege.be/handle/2268/30945","pdf_url":null,"source":{"id":"https://openalex.org/S4306400651","display_name":"Open Repository and Bibliography (University of Li\u00e8ge)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I157674565","host_organization_name":"University of Li\u00e8ge","host_organization_lineage":["https://openalex.org/I157674565"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Critical Care Medicine, 29 (4), 765-769 (2001)","raw_type":"http://purl.org/coar/resource_type/c_6501"},{"id":"pmh:oai:pure.rug.nl:openaire_cris_publications/9409cebc-41aa-41f3-a79d-63a53f5a1d8e","doi":null,"is_oa":false,"landing_page_url":"https://hdl.handle.net/11370/9409cebc-41aa-41f3-a79d-63a53f5a1d8e","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Reinhart, K, Menges, T, Gardlund, B, Zwaveling, JH, Smithes, M, Vincent, JL, Tellado, JM, Salgado-Remigio, A, Zimlichman, R, Withington, S, Tschaikowsky, K, Brase, R, Damas, P, Kupper, H, Kempeni, J, Eiselstein, J, Kaul, M & AFELIMOMAB Sepsis Study Grp 2001, 'Randomized, placebo-controlled trial of the anti-tumor necrosis factor antibody fragment afelimomab in hyperinflammatory response during severe sepsis : The RAMSES Study', Critical Care Medicine, vol. 29, no. 4, pp. 765-769.","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:rug:oai:pure.rug.nl:publications/9409cebc-41aa-41f3-a79d-63a53f5a1d8e","doi":null,"is_oa":false,"landing_page_url":"https://research.rug.nl/en/publications/9409cebc-41aa-41f3-a79d-63a53f5a1d8e","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Critical Care Medicine, 29(4), 765 - 769. LIPPINCOTT WILLIAMS &amp; WILKINS","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":22,"referenced_works":["https://openalex.org/W95884546","https://openalex.org/W204546040","https://openalex.org/W1898928487","https://openalex.org/W1968713831","https://openalex.org/W1981003900","https://openalex.org/W1990935230","https://openalex.org/W2006887827","https://openalex.org/W2029512625","https://openalex.org/W2030879735","https://openalex.org/W2034797939","https://openalex.org/W2054766380","https://openalex.org/W2059707463","https://openalex.org/W2076452720","https://openalex.org/W2085208748","https://openalex.org/W2093799856","https://openalex.org/W2104631810","https://openalex.org/W2114563054","https://openalex.org/W2120599813","https://openalex.org/W2156643886","https://openalex.org/W2325491525","https://openalex.org/W2334453840","https://openalex.org/W4322387790"],"related_works":["https://openalex.org/W2104010066","https://openalex.org/W4229819045","https://openalex.org/W2114563054","https://openalex.org/W2034797939","https://openalex.org/W2414367703","https://openalex.org/W2153961239","https://openalex.org/W2098101596","https://openalex.org/W4322387790","https://openalex.org/W76818083","https://openalex.org/W2057979643"],"abstract_inverted_index":{"OBJECTIVE:":[0],"This":[1],"study":[2,150],"investigated":[3],"whether":[4],"treatment":[5,265],"with":[6,20,72,99,225,230,245],"the":[7,59,160,174,190,201,261],"anti-tumor":[8],"necrosis":[9],"factor-alpha":[10],"monoclonal":[11],"antibody":[12],"afelimomab":[13,89,126,209,226],"would":[14,165],"improve":[15],"survival":[16],"in":[17,39,43,173,189,200,255,260],"septic":[18,52],"patients":[19,53,176,192,206],"serum":[21,68],"interleukin":[22],"(IL)-6":[23],"concentrations":[24,80],"of":[25,50,61,81,120,123,179,195,216,221],">1000":[26,82],"pg/mL.":[27],"DESIGN:":[28],"Multicenter,":[29],"double-blind,":[30],"randomized,":[31],"placebo-controlled":[32],"study.":[33],"SETTING:":[34],"Eighty-four":[35],"intensive":[36,139],"care":[37,140],"units":[38],"academic":[40],"medical":[41],"centers":[42],"Europe":[44],"and":[45,56,110,138,210],"Israel.":[46],"PATIENTS:":[47],"A":[48,250],"total":[49],"944":[51],"were":[54,84,107,111,212],"screened":[55],"stratified":[57],"by":[58],"results":[60],"a":[62,73,100],"rapid":[63],"qualitative":[64],"immunostrip":[65,238],"test":[66,75,103,203,239],"for":[67,114,133],"IL-6":[69,79,102,202,237],"concentrations.":[70],"Patients":[71,98],"positive":[74,205],"kit":[76,204],"result":[77],"indicating":[78],"pg/mL":[83],"randomized":[85,109,191,207],"to":[86,208],"receive":[87],"either":[88],"(n":[90,95,104],"=":[91,96,105],"224)":[92,217],"or":[93,127],"placebo":[94,129,211],"222).":[97],"negative":[101],"498)":[106,180],"not":[108,166,228,268],"followed":[112],"up":[113],"28":[115],"days.":[116,135],"INTERVENTIONS:":[117],"Treatment":[118,224],"consisted":[119],"15-min":[121],"infusions":[122],"1":[124],"mg/kg":[125],"matching":[128],"every":[130],"8":[131],"hrs":[132],"3":[134],"Standard":[136],"surgical":[137],"therapy":[141],"was":[142,151,181,227,258],"otherwise":[143],"delivered.":[144],"MEASUREMENTS":[145],"AND":[146],"MAIN":[147],"RESULTS:":[148],"The":[149,169,197,236,264],"terminated":[152],"prematurely":[153],"after":[154],"an":[155],"interim":[156],"analysis":[157],"estimated":[158],"that":[159,187],"primary":[161],"efficacy":[162],"end":[163],"points":[164],"be":[167],"met.":[168],"28-day":[170],"mortality":[171,198,248,256],"rate":[172,257],"nonrandomized":[175],"(39.6%,":[177],"197":[178],"significantly":[182,246],"lower":[183],"(p":[184],"<.001)":[185],"than":[186],"found":[188,259],"(55.8%,":[193],"249":[194],"446).":[196],"rates":[199],"similar,":[213],"54.0%":[214],"(121":[215],"vs.":[218],"57.7%":[219],"(128":[220],"222),":[222],"respectively.":[223],"associated":[229],"any":[231],"particular":[232],"adverse":[233],"events.":[234],"CONCLUSIONS:":[235],"identified":[240],"two":[241],"distinct":[242],"sepsis":[243],"populations":[244],"different":[247],"rates.":[249],"small":[251],"(3.7%)":[252],"absolute":[253],"reduction":[254],"afelimomab-treated":[262],"patients.":[263],"difference":[266],"did":[267],"reach":[269],"statistical":[270],"significance.":[271]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":10},{"year":2023,"cited_by_count":8},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":9},{"year":2019,"cited_by_count":9},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":7},{"year":2013,"cited_by_count":9},{"year":2012,"cited_by_count":11}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}